近日，彭博社援引知情人士的话称，由于投资者对制药商表现出浓厚兴趣，传奇生物正考虑在美国以外进行二次上市。一时间，市场纷纷猜测传奇生物可能的上市地。从外媒报道来看，传奇生物已经与潜在顾问讨论了上市方案，上市地点或是香港、新加坡或伦敦。不过该名知情人士亦称，相关考虑仍在进行中，传奇生物也可能决定不进行二次上市。今年以来，传奇生物在纳斯达克的市值上涨了3.89%，目前市值已达66.59亿美元。考虑二次...
Source Link近日，彭博社援引知情人士的话称，由于投资者对制药商表现出浓厚兴趣，传奇生物正考虑在美国以外进行二次上市。一时间，市场纷纷猜测传奇生物可能的上市地。从外媒报道来看，传奇生物已经与潜在顾问讨论了上市方案，上市地点或是香港、新加坡或伦敦。不过该名知情人士亦称，相关考虑仍在进行中，传奇生物也可能决定不进行二次上市。今年以来，传奇生物在纳斯达克的市值上涨了3.89%，目前市值已达66.59亿美元。考虑二次...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.